1-7 of 7
Syed M Rizvi
Close
Sort by
Journal Articles

Ascorbate Deficiency Is Associated with Severity of Cytokine Release Syndrome Following Therapy with Chimeric Antigen Receptor T-Cells

Ankit Kansagra, Dheepthi P. Ramasamy, Aishwarya Sannareddy, Qing Ding, Alexa Wilden, Cedric B. Robinson, Helen Stephens, Fatma Kalkan, Larry D. Anderson, Jr., Farrukh T. Awan, Robert H. Collins, Gurbakhash Kaur, Yazan F. Madanat, Prapti Patel, Syed M Rizvi, Praveen Ramakrishnan, John Sweetenham, Madhuri Vusirikala, Michalis Agathocleous, Stephen Chung
Journal: Blood
Blood (2021) 138 (Supplement 1): 4801.
https://doi.org/10.1182/blood-2021-153929
Published: 2021
Journal Articles

T-Cell Telomere Length As a Biomarker to Predict Outcome in Patients Receiving CAR-T Immunotherapy

Enzo Tedone, Mohammed Sayed, Tsung-Po Lai, Aishwarya Sannareddy, Dheepthi P. Ramasamy, Larry D. Anderson, Jr., Farrukh T. Awan, Gurbakhash Kaur, Stephen Chung, Yazan F. Madanat, Prapti Patel, Syed M Rizvi, Praveen Ramakrishnan, Madhuri Vusirikala, Robert H. Collins, John Sweetenham, Jerry Shay, Ankit Kansagra
Journal: Blood
Blood (2021) 138 (Supplement 1): 4798.
https://doi.org/10.1182/blood-2021-153183
Published: 2021
Journal Articles

Single-Agent Rituximab and Ultra-Low-Dose Adaptive Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma

Meredith Jackson, Sean All, Samantha Brocklehurst, Neil B Desai, Jennifer L Shah, Syed M Rizvi, Farrukh T. Awan, Praveen Ramakrishnan Geethakumari, Kiran A Kumar
Journal: Blood
Blood (2021) 138 (Supplement 1): 4510.
https://doi.org/10.1182/blood-2021-154354
Published: 2021
Journal Articles

Hypofractionated Low-Dose Total Skin Electron Beam Therapy for Primary Cutaneous T-Cell Lymphoma: Analysis of Efficacy and Toxicity

Sofia F Yi, Akshat M Patel, Syed M Rizvi, Praveen Ramakrishnan Geethakumari, Jennifer L Shah, Neil B Desai, Heather W Goff, Kiran A Kumar
Journal: Blood
Blood (2021) 138 (Supplement 1): 1372.
https://doi.org/10.1182/blood-2021-153958
Published: 2021
Journal Articles

CAR T-Cell Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL): A 'Real-World' Analysis of Patterns of Failure and Role of Bridging Therapy

Revathi Ravella, BA, Elizabeth Ren Zhang-Velten, MD PhD, Farrukh T Awan, MD, Syed M Rizvi, MD, Jennifer L Shah, MD, Neil B Desai, MD MHS, Praveen Ramakrishnan Geethakumari, MD MS, Kiran A Kumar, MD MBA
Journal: Blood
Blood (2020) 136 (Supplement 1): 22–23.
https://doi.org/10.1182/blood-2020-141445
Published: 2020
Journal Articles

A Radiomic Machine Learning Model to Predict Treatment Response to Methotrexate and Survival Outcomes in Primary Central Nervous System Lymphoma (PCNSL)

Omer M Ali, MD, Sahil S Nalawade, MS, Yin Xi, PhD, Ben Wagner, BM, Alexander Mazal, MD, Shane Ahlers, MD, Syed M Rizvi, MD, Farrukh T Awan, MD, Kiran A Kumar, MD MBA, Neil B Desai, MD MHS, Joseph A Maldjian, MD, Marco C Pinho, MD, Praveen Ramakrishnan Geethakumari, MD MS
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
https://doi.org/10.1182/blood-2020-141941
Published: 2020
Journal Articles

Comparison of Demographics, Treatment Patterns and Outcomes Among Primary Central Nervous System Lymphoma (PCNSL) Patients Treated at a Safety-Net Hospital Versus a Tertiary Academic Institution within the Same Healthcare System

Akshat M Patel, Omer M Ali, MD, Radhika Kainthla, MD, Syed M Rizvi, MD, Farrukh T Awan, MD, Neil B Desai, MD MHS, Robert Timmerman, MD, Kiran A Kumar, MD MBA, Praveen Ramakrishnan Geethakumari, MD MS
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–12.
https://doi.org/10.1182/blood-2020-138568
Published: 2020